TAZTIA XT Trademark

Trademark Overview

On Monday, August 30, 2010, a trademark application was filed for TAZTIA XT with the United States Patent and Trademark Office. The USPTO has given the TAZTIA XT trademark a serial number of 85118870. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, October 13, 2023. This trademark is owned by Watson Pharmaceuticals, Inc.. The TAZTIA XT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the treatment of Angina and Hypertension
taztia xt

General Information

Serial Number85118870
Word MarkTAZTIA XT
Filing DateMonday, August 30, 2010
Status800 - REGISTERED AND RENEWED
Status DateFriday, October 13, 2023
Registration Number4263084
Registration DateTuesday, December 25, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2012

Trademark Statements

Goods and ServicesPharmaceutical product for the treatment of Angina and Hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 3, 2010
Primary Code005
First Use Anywhere DateThursday, April 10, 2003
First Use In Commerce DateThursday, April 10, 2003

Trademark Owner History

Party NameACTAVIS HOLDCO US, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameACTAVIS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054
Party NameWatson Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCorona, CA 92880
Party NameWatson Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCorona, CA 92880
Party NameWatson Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCorona, CA 92880

Trademark Events

Event DateEvent Description
Friday, October 13, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, October 13, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, October 13, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, October 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 12, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, December 25, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, November 24, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 24, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, November 24, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 2, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, December 25, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, January 19, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 28, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 25, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, October 9, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 5, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 3, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 16, 2012AMENDMENT FROM APPLICANT ENTERED
Thursday, August 16, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 30, 2012PAPER RECEIVED
Wednesday, January 25, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 25, 2012NON-FINAL ACTION E-MAILED
Wednesday, January 25, 2012NON-FINAL ACTION WRITTEN
Wednesday, January 4, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 3, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 3, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2011NON-FINAL ACTION E-MAILED
Friday, July 1, 2011NON-FINAL ACTION WRITTEN
Friday, June 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 17, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2011ASSIGNED TO LIE
Tuesday, May 31, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 31, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 29, 2010NON-FINAL ACTION MAILED
Sunday, November 28, 2010NON-FINAL ACTION WRITTEN
Saturday, November 27, 2010ASSIGNED TO EXAMINER
Friday, September 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 2, 2010NEW APPLICATION ENTERED

Related Keywords

taztia hypertension angina treatment product pharmaceutical